EXUBERA Side Effects

5641830-8 | Cardiac Failure Congestive
on Nov 20, 2007 Female patient from UNITED STATES , weighting 160.9 lb, was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. Exubera dosage: Daily Dose:7mg-text:tdd: 1 Mg Qd/3 Mg Bid. Patient was hospitalized.

5637333-7 | Bronchitis Chronic, Dysgeusia, Hypersensitivity, Pulmonary Function Test Decreased
Patient was taking Exubera (View Usage). Patient had the following side effects: bronchitis chronic, dysgeusia, hypersensitivity, pulmonary function test decreased on Feb 15, 2008 from GERMANY Additional patient health information: Female patient , weighting 189.6 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: Daily Dose:6mg. During the same period patient was treated with AGGRENOX (View Aggrenox Review and Aggrenox Label ), ATACAND HCT (View Atacand Hct Review and Atacand Hct Label ), METODURA (View Metodura Review and Metodura Label ), FURO (View Furo Review and Furo Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

5616041-2 | Dyspnoea, Hypoglycaemia, Respiratory Disorder, Tachypnoea
Adverse event was reported on Jan 30, 2008 by a Female patient taking Exubera (View Usage) (Dosage: Daily Dose:7mg) was diagnosed with diabetes mellitus and. Location: BRAZIL , weighting 127.9 lb, After Exubera was administered, patient had the following side effects: dyspnoea, hypoglycaemia, respiratory disorder, tachypnoea. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ).

5615923-5 | Blood Glucose Decreased, Loss Of Consciousness, Unresponsive To Stimuli
on Jan 28, 2008 Male patient from UNITED STATES , weighting 188.1 lb, was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, loss of consciousness, unresponsive to stimuli. Exubera dosage: Text:3 Mg. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), ENULOSE (View Enulose Review and Enulose Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), NEOMYCIN (View Neomycin Review and Neomycin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ). Patient was hospitalized.


5608748-8 | Interstitial Lung Disease
on Jan 29, 2008 Male patient from UNITED STATES , 61 years of age, weighting 222.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: interstitial lung disease. Exubera dosage: 1 Mg Bid Inhaled.

5607121-6 | Embolism
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: embolism on Jan 18, 2008 from UNITED KINGDOM Additional patient health information: Female patient , weighting 215.6 lb, was diagnosed with diabetes mellitus, headache (What is headache?) and. Exubera dosage: . During the same period patient was treated with DOXAZOSIN (View Doxazosin Review and Doxazosin Label ).

5603043-5 | Left Ventricular Dysfunction
Adverse event was reported on Jan 14, 2008 by a Male patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: NETHERLANDS , weighting 185.2 lb, Patient experienced the following unwanted or unexpected effects: left ventricular dysfunction. During the same period patient was treated with METFORMIN HCL (Daily Dose:2000mg) (View Metformin Hcl Review and Metformin Hcl Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

5601870-1 | Cerebrovascular Accident
on Jan 18, 2008 Female patient from UNITED STATES , weighting 190.0 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: cerebrovascular accident. Exubera dosage: . Patient was hospitalized.

5601862-2 | Blood Glucose Decreased, Loss Of Consciousness, Unresponsive To Stimuli
on Jan 15, 2008 Male patient from UNITED STATES , weighting 188.4 lb, was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: blood glucose decreased, loss of consciousness, unresponsive to stimuli. Exubera dosage: Text:3 Mg. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), ENULOSE (View Enulose Review and Enulose Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), NEOMYCIN (View Neomycin Review and Neomycin Label ). Patient was hospitalized.

5599409-2 | Blood Glucose Fluctuation, Blood Glucose Increased, Hypoglycaemia, Loss Of Consciousness
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, blood glucose increased, hypoglycaemia, loss of consciousness on Jan 14, 2008 from UNITED KINGDOM Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with diabetes mellitus and. Exubera dosage: . During the same period patient was treated with ASPIRIN 10GR TIMED DISINTEGRATION TAB (View Aspirin 10gr Timed Disintegration Tab Review and Aspirin 10gr Timed Disintegration Tab Label ), LIPITOR (View Lipitor Review and Lipitor Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ).

5596440-8 | Dyspnoea, Hypoglycaemia, Respiratory Disorder, Tachypnoea
Adverse event was reported on Jan 07, 2008 by a Female patient taking Exubera (View Usage) (Dosage: Daily Dose:7mg) was diagnosed with diabetes mellitus and. Location: BRAZIL , weighting 127.9 lb, Patient had the following side effects: dyspnoea, hypoglycaemia, respiratory disorder, tachypnoea. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ).

5592413-X | Metastasis
on Jan 07, 2008 Female patient from BRAZIL , weighting 105.8 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: metastasis. Exubera dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), PANCREATIN TRIPLE STRENGTH CAP (View Pancreatin Triple Strength Cap Review and Pancreatin Triple Strength Cap Label ).

5592388-3 | Chest Pain, Dyspnoea, Respiratory Distress
on Jan 10, 2008 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, respiratory distress. Exubera dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

5587174-4 | Embolism
Patient was taking Exubera (View Usage). Patient had the following side effects: embolism on Jan 03, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, was diagnosed with diabetes mellitus and. Exubera dosage: .

5584702-X |
Adverse event was reported on Dec 27, 2007 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: BRAZIL , weighting 105.8 lb, . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), PANCREATIN TRIPLE STRENGTH CAP (View Pancreatin Triple Strength Cap Review and Pancreatin Triple Strength Cap Label ).

5581785-8 | Chest Injury, Chest Pain, Dyspnoea, Essential Hypertension, Fall, Hypercholesterolaemia, Lung Disorder, Lymphadenopathy, Non-small Cell Lung Cancer
on Dec 26, 2007 Male patient from UNITED STATES , weighting 242.1 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: chest injury, chest pain (What is chest pain?), dyspnoea, essential hypertension, fall (What is fall?), hypercholesterolaemia, lung disorder, lymphadenopathy, non-small cell lung cancer. Exubera dosage: . During the same period patient was treated with VYTORIN (View Vytorin Review and Vytorin Label ), COZAAR (View Cozaar Review and Cozaar Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), LANTUS (View Lantus Review and Lantus Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), TRICOR (View Tricor Review and Tricor Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), NOVOLOG (View Novolog Review and Novolog Label ).

5580753-X | Abdominal Pain, Abdominal Pain Upper, Blood Glucose Decreased, Blood Glucose Increased, Chest Pain, Dyspepsia, Gastritis, Inflammation, Malaise
on Dec 24, 2007 Female patient from UNITED STATES , weighting 238.1 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, blood glucose decreased, blood glucose increased, chest pain (What is chest pain?), dyspepsia, gastritis, inflammation, malaise. Exubera dosage: .

5579768-7 | Blood Glucose Decreased, Dyspnoea, Wheezing
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: blood glucose decreased, dyspnoea, wheezing on Dec 21, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 93.92 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), ACTOS (Daily Dose:45mg) (View Actos Review and Actos Label ), ALPRAZOLAM (Daily Dose:3mg) (View Alprazolam Review and Alprazolam Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), FOLTX (View Foltx Review and Foltx Label ), SYNTHROID (Daily Dose:50mcg) (View Synthroid Review and Synthroid Label ), PREMARIN (View Premarin Review and Premarin Label ).

5577480-1 | Abortion Spontaneous
Adverse event was reported on Dec 18, 2007 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: abortion spontaneous.

5577317-0 | Blood Glucose Decreased, Dyspnoea, Wheezing
on Dec 18, 2007 Female patient from UNITED STATES , weighting 93.92 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: blood glucose decreased, dyspnoea, wheezing. Exubera dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), ACTOS (Daily Dose:45mg) (View Actos Review and Actos Label ), ALPRAZOLAM (Daily Dose:3mg) (View Alprazolam Review and Alprazolam Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), FOLTX (View Foltx Review and Foltx Label ), SYNTHROID (Daily Dose:50mcg) (View Synthroid Review and Synthroid Label ), PREMARIN (View Premarin Review and Premarin Label ).

5577136-5 | Cardiac Failure Congestive, Cough, Dyspnoea, Exercise Tolerance Decreased, Wheezing
on Dec 17, 2007 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: cardiac failure congestive, cough, dyspnoea, exercise tolerance decreased, wheezing. Exubera dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5570197-9 | Coronary Artery Stenosis, Lung Neoplasm Malignant
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery stenosis, lung neoplasm malignant on Dec 11, 2007 from Additional patient health information: Male patient , weighting 275.6 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: Freq:3x:daily. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), NEBILET (View Nebilet Review and Nebilet Label ), CARMEN (View Carmen Review and Carmen Label ), SORTIS (Daily Dose:40mg) (View Sortis Review and Sortis Label ), THIOCTACID (View Thioctacid Review and Thioctacid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COAPROVEL (Daily Dose:300mg) (View Coaprovel Review and Coaprovel Label ). Patient was hospitalized.

5570157-8 | Blood Glucose Increased, Cerebrovascular Disorder, Fatigue, Pleuritic Pain, Somnolence
Adverse event was reported on Dec 11, 2007 by a Male patient taking Exubera (View Usage) (Dosage: Daily Dose:15mg-text:3-1mg) was diagnosed with diabetes mellitus and. Location: MEXICO , weighting 185.2 lb, Patient had the following side effects: blood glucose increased, cerebrovascular disorder, fatigue, pleuritic pain, somnolence. During the same period patient was treated with CAPTOPRIL (View Captopril Review and Captopril Label ), SECOTEX (View Secotex Review and Secotex Label ).

5564001-2 | Asthma, Blood Glucose Increased, Cardiac Disorder, Chest Pain, Cold Sweat, Cough, Diabetes Mellitus Inadequate Control, Dry Throat, Dyspnoea
on Dec 05, 2007 Male patient from UNITED KINGDOM , weighting 253.5 lb, was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia, myocardial ischaemia and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: asthma (What is asthma?), blood glucose increased, cardiac disorder, chest pain (What is chest pain?), cold sweat, cough, diabetes mellitus inadequate control, dry throat, dyspnoea. Exubera dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LANTUS (View Lantus Review and Lantus Label ).

5558190-3 | Blood Glucose Increased, Cerebrovascular Disorder, Fatigue, Pleuritic Pain, Somnolence
on Dec 03, 2007 Male patient from MEXICO , weighting 185.2 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, cerebrovascular disorder, fatigue, pleuritic pain, somnolence. Exubera dosage: Daily Dose:15mg-freq:interval: Daily. During the same period patient was treated with CAPTOPRIL (View Captopril Review and Captopril Label ), SECOTEX (View Secotex Review and Secotex Label ).

5555788-3 | Dry Mouth, Dyspnoea, Hyperglycaemia, Hypoglycaemia, Oral Pain, Viral Infection, Vomiting
Patient was taking Exubera (View Usage). Patient had the following side effects: dry mouth, dyspnoea, hyperglycaemia, hypoglycaemia, oral pain, viral infection (What is viral infection?), vomiting on Dec 05, 2007 from UNITED KINGDOM Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with diabetes mellitus and. Exubera dosage: Daily Dose:8mg. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CIPRAMIL (View Cipramil Review and Cipramil Label ). Patient was hospitalized.

5554981-3 | Abasia, Dyspnoea, Emphysema
Adverse event was reported on Dec 04, 2007 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension and. Location: UNITED STATES , weighting 190.0 lb, After Exubera was administered, patient had the following side effects: abasia, dyspnoea, emphysema. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5549683-3 | Dyspnoea, Lung Disorder, Respiratory Gas Exchange Disorder
on Sep 27, 2007 Male patient from UNITED STATES , 46 years of age, was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, lung disorder, respiratory gas exchange disorder. Exubera dosage: .

5549671-7 | Cough, Dyspnoea, Fatigue, Forced Expiratory Volume Decreased, Lung Disorder
on Sep 24, 2007 Male patient from UNITED STATES , 44 years of age, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: cough, dyspnoea, fatigue, forced expiratory volume decreased, lung disorder. Exubera dosage: .

5549659-6 | Chest Pain, Myocardial Infarction
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: chest pain (What is chest pain?), myocardial infarction on Sep 04, 2007 from UNITED STATES Additional patient health information: Male patient , 60 years of age, . Exubera dosage: .

5549656-0 | Blood Glucose Increased
Adverse event was reported on Oct 02, 2007 by a Female patient taking Exubera (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, weighting 160.3 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROTONIX (View Protonix Review and Protonix Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

5549626-2 | Chest Pain, Cough, Pulmonary Function Test Decreased
on Aug 23, 2007 Female patient from UNITED STATES , 60 years of age, was treated with Exubera (View Usage). Patient had the following side effects: chest pain (What is chest pain?), cough, pulmonary function test decreased. Exubera dosage: .

5549622-5 | Blood Glucose Increased
on Aug 17, 2007 Male patient from UNITED STATES , 74 years of age, weighting 215.0 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: blood glucose increased. Exubera dosage: 9 Mg (3 Mg, 1 In 1 D), Inhalation. During the same period patient was treated with AVANDIA (View Avandia Review and Avandia Label ).

5549545-1 | Forced Expiratory Volume Decreased
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: forced expiratory volume decreased on Aug 31, 2007 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 195.1 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: 8mg Brkfst, 5mglunch, 9mg Dinner (3 In 1 D), Inhalation. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), METFORMIN XR (METFORMIN) (View Metformin Xr (metformin) Review and Metformin Xr (metformin) Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ISOSORBIDE (ISOSORBIDE) (View Isosorbide (isosorbide) Review and Isosorbide (isosorbide) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), NOVOLOG (View Novolog Review and Novolog Label ).

5549523-2 | Blood Glucose Increased
Adverse event was reported on Sep 01, 2007 by a Male patient taking Exubera (View Usage) (Dosage: 3 Mg (1 Mg, 3 In 1 D), Inhalation) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 69 years of age, weighting 198.0 lb, Patient had the following side effects: blood glucose increased. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ACCUPRIL (QUINAPRIL HYDROCLORIDE) (View Accupril (quinapril Hydrocloride) Review and Accupril (quinapril Hydrocloride) Label ), VYTORIN (View Vytorin Review and Vytorin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

5546844-4 | Cellulitis
on Nov 30, 2007 Male patient from UNITED STATES , weighting 139.3 lb, was diagnosed with type 1 diabetes mellitus, type 2 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: cellulitis (What is cellulitis?). Exubera dosage: Daily Dose:12mg. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

5542855-3 | Blood Glucose Decreased, Dyspnoea, Wheezing
on Nov 28, 2007 Female patient from UNITED STATES , weighting 207.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, dyspnoea, wheezing. Exubera dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), ACTOS (Daily Dose:45mg) (View Actos Review and Actos Label ), ALPRAZOLAM (Daily Dose:3mg) (View Alprazolam Review and Alprazolam Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), FOLTX (View Foltx Review and Foltx Label ), SYNTHROID (Daily Dose:50mcg) (View Synthroid Review and Synthroid Label ), PREMARIN (View Premarin Review and Premarin Label ).

5537755-9 | Chest Pain, Cough, Dysgeusia, Dyspnoea, Feeling Abnormal, Haemoptysis, Haemorrhage, Productive Cough
Patient was taking Exubera (View Usage). Patient had the following side effects: chest pain (What is chest pain?), cough, dysgeusia, dyspnoea, feeling abnormal, haemoptysis, haemorrhage, productive cough on Nov 29, 2007 from UNITED KINGDOM Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: . During the same period patient was treated with INSUMAN COMB 25 (View Insuman Comb 25 Review and Insuman Comb 25 Label ), HUMALOG MIX 25 (View Humalog Mix 25 Review and Humalog Mix 25 Label ).

5535298-X | Phrenic Nerve Paralysis, Pneumonitis, Respiratory Distress, Sleep Apnoea Syndrome
Adverse event was reported on Dec 04, 2007 by a Male patient taking Exubera (View Usage) (Dosage: ) . Location: UNITED STATES , 54 years of age, After Exubera was administered, patient had the following side effects: phrenic nerve paralysis, pneumonitis, respiratory distress, sleep apnoea syndrome. During the same period patient was treated with AXILLARY BLOCK (View Axillary Block Review and Axillary Block Label ). Patient was hospitalized.

5532376-6 | Cardiac Arrest, Myocardial Infarction
on Nov 21, 2007 Male patient from UNITED STATES , 46 years of age, weighting 306.0 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), myocardial infarction. Exubera dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), NASONEX (View Nasonex Review and Nasonex Label ).

5530915-2 | Chest Pain, Respiratory Distress
on Nov 26, 2007 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: chest pain (What is chest pain?), respiratory distress. Exubera dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5524277-4 | Coronary Artery Stenosis, Lung Neoplasm Malignant
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: coronary artery stenosis, lung neoplasm malignant on Nov 11, 2007 from Additional patient health information: Male patient , weighting 275.6 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: Freq:3x:daily. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), NEBILET (View Nebilet Review and Nebilet Label ), CARMEN (View Carmen Review and Carmen Label ), SORTIS (Daily Dose:40mg) (View Sortis Review and Sortis Label ), THIOCTACID (View Thioctacid Review and Thioctacid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COAPROVEL (Daily Dose:300mg) (View Coaprovel Review and Coaprovel Label ). Patient was hospitalized.

5524217-8 | Face Oedema
Adverse event was reported on Nov 13, 2007 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 29 years of age, Patient experienced the following unwanted or unexpected effects: face oedema. During the same period patient was treated with ANCEF (View Ancef Review and Ancef Label ), LACTATED RINGER'S (View Lactated Ringer's Review and Lactated Ringer's Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), AVAPRO (View Avapro Review and Avapro Label ), LANTUS (View Lantus Review and Lantus Label ).

5522545-3 | Chest Injury, Chest Pain, Dyspnoea, Essential Hypertension, Fall, Hypercholesterolaemia, Lung Disorder, Lymphadenopathy, Non-small Cell Lung Cancer
on Nov 09, 2007 Male patient from UNITED STATES , weighting 242.1 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: chest injury, chest pain (What is chest pain?), dyspnoea, essential hypertension, fall (What is fall?), hypercholesterolaemia, lung disorder, lymphadenopathy, non-small cell lung cancer. Exubera dosage: . During the same period patient was treated with VYTORIN (View Vytorin Review and Vytorin Label ), COZAAR (View Cozaar Review and Cozaar Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), LANTUS (View Lantus Review and Lantus Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), TRICOR (View Tricor Review and Tricor Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), NOVOLOG (View Novolog Review and Novolog Label ).

5522507-6 | Hypoglycaemia
on Nov 09, 2007 Male patient from UNITED STATES , weighting 160.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: hypoglycaemia. Exubera dosage: . During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ).

5522378-8 | Oesophageal Oedema
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal oedema on Nov 08, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 139.3 lb, was diagnosed with type 1 diabetes mellitus, type 2 diabetes mellitus and. Exubera dosage: Daily Dose:12mg. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

5518525-4 | Chest Discomfort, Chest Pain, Lung Disorder
Adverse event was reported on Nov 07, 2007 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, hypertension, hypersensitivity, oedema peripheral and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: chest discomfort, chest pain (What is chest pain?), lung disorder. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), ASTELIN (View Astelin Review and Astelin Label ), FLOVENT (View Flovent Review and Flovent Label ), VYTORIN (View Vytorin Review and Vytorin Label ), LASIX (View Lasix Review and Lasix Label ).

5510337-0 | Oesophageal Oedema
on Oct 29, 2007 Male patient from UNITED STATES , weighting 139.3 lb, was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: oesophageal oedema. Exubera dosage: Daily Dose:12mg. Patient was hospitalized.

5509881-1 | Blood Glucose Decreased, Glycosylated Haemoglobin Increased, Tremor
on Nov 07, 2007 Male patient from UNITED STATES , 54 years of age, weighting 169.0 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, glycosylated haemoglobin increased, tremor. Exubera dosage: . During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), LANTUS (View Lantus Review and Lantus Label ), ZETIA (View Zetia Review and Zetia Label ).

5505742-2 | Coronary Artery Stenosis, Lung Neoplasm Malignant
Patient was taking Exubera (View Usage). Patient had the following side effects: coronary artery stenosis, lung neoplasm malignant on Oct 25, 2007 from GERMANY Additional patient health information: Female patient , weighting 275.6 lb, . Exubera dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), NEBILET (View Nebilet Review and Nebilet Label ), CARMEN (View Carmen Review and Carmen Label ), SORTIS (Daily Dose:40mg) (View Sortis Review and Sortis Label ), THIOCTACID (View Thioctacid Review and Thioctacid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COAPROVEL (Daily Dose:300mg) (View Coaprovel Review and Coaprovel Label ). Patient was hospitalized.